Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1729-1735
Published online before print May 31, 2007, doi: 10.1161/ATVBAHA.107.143909
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/8/1729    most recent
ATVBAHA.107.143909v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wenzel, P.
Right arrow Articles by Daiber, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wenzel, P.
Right arrow Articles by Daiber, A.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1729.)
© 2007 American Heart Association, Inc.


Vascular Biology

Heme Oxygenase-1

A Novel Key Player in the Development of Tolerance in Response to Organic Nitrates

Philip Wenzel; Matthias Oelze; Meike Coldewey; Marcus Hortmann; Andreas Seeling; Ulrich Hink; Hanke Mollnau; Dirk Stalleicken; Henry Weiner; Jochen Lehmann; Huige Li; Ulrich Förstermann; Thomas Münzel; Andreas Daiber

From the II. Medizinische Klinik (P.W., M.O., M.C., U.H., H.M., T.M., A.D.), Johannes-Gutenberg-Universität Mainz, Germany; Institut für Pharmakologie (M.H., H.L., U.F.), Johannes-Gutenberg-Universität Mainz, Germany; Institut für Pharmazie (A.S., J.L.), Friedrich-Schiller-Universität Jena, Germany; Actavis Deutschland GmbH (D.S.), Langenfeld, Germany; and the Department of Biochemistry (H.W.), Purdue University, West Lafayette, Ind.

Correspondence Prof Dr Thomas Münzel, II. Medizinische Klinik, Johannes-Gutenberg-Universität Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. E-mail tmuenzel{at}uni-mainz.de

Objective— Nitrate tolerance is likely attributable to an increased production of reactive oxygen species (ROS) leading to an inhibition of the mitochondrial aldehyde dehydrogenase (ALDH-2), representing the nitroglycerin (GTN) and pentaerythrityl tetranitrate (PETN) bioactivating enzyme, and to impaired nitric oxide bioactivity and signaling. We tested whether differences in their capacity to induce heme oxygenase-1 (HO-1) might explain why PETN and not GTN therapy is devoid of nitrate and cross-tolerance.

Methods and Results— Wistar rats were treated with PETN or GTN (10.5 or 6.6 µg/kg/min for 4 days). In contrast to GTN, PETN did not induce nitrate tolerance or cross-tolerance as assessed by isometric tension recordings in isolated aortic rings. Vascular protein and mRNA expression of HO-1 and ferritin were increased in response to PETN but not GTN. In contrast to GTN therapy, NO signaling, ROS formation, and the activity of ALDH-2 (as assessed by an high-performance liquid chromatography–based method) were not significantly influenced by PETN. Inhibition of HO-1 expression by apigenin induced "tolerance" to PETN whereas HO-1 gene induction by hemin prevented tolerance in GTN treated rats.

Conclusions— HO-1 expression and activity appear to play a key role in the development of nitrate tolerance and might represent an intrinsic antioxidative mechanism of therapeutic interest.

Tolerance to nitroglycerin is likely attributable to an increased production of reactive oxygen species and an inhibition of its bioactivating enzyme. Pentaerythrityl tetranitrate (PETN) therapy is devoid of tolerance, potentially because of HO-1 induction. Inhibition of HO-1 expression induced "tolerance" to PETN, whereas HO-1 induction prevented tolerance in nitroglycerin-treated rats.


Key Words: organic nitrates • nitrate tolerance • heme oxygenase-1 • reactive oxygen species


Related Article:

Combating Nitrate Tolerance: A Novel Endogenous Mechanism
David D. Gutterman
Arterioscler. Thromb. Vasc. Biol. 2007 27: 1673-1676. [Extract] [Full Text] [PDF]